The Autoimmune Cell Therapy (ACT) Research Hub operates under a defined set of objectives that serve as its guiding principles. 

The objectives used are as follows:

• Collective decision-making by representatives from various departments to select clinical trials that will create a diverse trial portfolio to serve patient needs

• Establish relationships with industry sponsors and academic institutions to aid in the creation of the diverse portfolio of clinical trials 

• Provide patient access to cell therapy clinical trials for autoimmune diseases

• Conduct trials ethically and safely for participants